Letter to Pharmac from Prof. Tony Mok, a world-renowned expert in precision medicine for lung cancer.

Professor Tony Mok of Hong Kong wrote to Pharmac in support of Lung Foundation New Zealand, because he was deeply concerned to hear the proposed Request for Proposal (RFP) for non-small cell lung cancer (NSCLC) has been further delayed.

Click to view his letter –
CU Medicine-active link